Browsing Tag
argenx
2 posts
VYVGART Sjögren’s setback sends argenx shares lower despite $1.5bn quarterly sales
argenx shares sink after the Phase 3 UNITY failure removes a major VYVGART expansion opportunity despite continued blockbuster sales growth.
October 11, 2026
OncoVerity accelerates AML treatment with Series A extension
OncoVerity, a leader in integrating bioinformatics with oncology drug development, has closed a Series A extension financing round,…
November 23, 2024